Discovery of Potent, Selective, and Orally Available IRE1α Inhibitors Demonstrating Comparable PD Modulation to IRE1 Knockdown in a Multiple Myeloma Model
- 15 May 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (11) , 8708-8729
Abstract
The lack of selective and safe in vivo IRE1α tool molecules has limited the evaluation of IRE1α as a viable target to treat multiple myeloma. Focus on improving the physicochemical properties of a literature compound by decreasing lipophilicity, molecular weight, and basicity allowed the discovery of a novel series with a favorable in vitro safety profile and good oral exposure. These efforts culminated in the identification of a potent and selective in vivo tool compound, G-5758, that was well tolerated following multiday oral administration of doses up to 500 mg/kg. G-5758 demonstrated comparable pharmacodynamic effects to induced IRE1 knockdown as measured by XBP1s levels in a multiple myeloma model (KMS-11).Keywords
This publication has 18 references indexed in Scilit:
- Identification of BRaf-Sparing Amino-Thienopyrimidines with Potent IRE1α Inhibitory ActivityACS Medicinal Chemistry Letters, 2020
- Binding to an Unusual Inactive Kinase Conformation by Highly Selective Inhibitors of Inositol-Requiring Enzyme 1α Kinase-EndoribonucleaseJournal of Medicinal Chemistry, 2019
- Protein misfolding in the endoplasmic reticulum as a conduit to human diseaseNature, 2016
- Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell ViabilityACS Medicinal Chemistry Letters, 2014
- Allosteric Inhibition of the IRE1α RNase Preserves Cell Viability and Function during Endoplasmic Reticulum StressCell, 2014
- Contributions of Molecular Properties to Drug PromiscuityJournal of Medicinal Chemistry, 2013
- Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche CompoundsChemMedChem, 2009
- ER Stress Triggers Apoptosis by Activating BH3-Only Protein BimCell, 2007
- Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling DataChemMedChem, 2007
- A quantitative assessment of hERG liability as a function of lipophilicityBioorganic & Medicinal Chemistry Letters, 2007